0.000USD0.000盘前交易 07/24, 09:30 (美东)
关键数据
46.820今开
49.500最高
2.99M成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
2.34%换手率
47.050昨收
46.820最低
115.00M成交额
亏损市盈率静
7.71市净率
0.00%股息率 TTM
-2.36%ROA
28.17052周最高
1.00量比
-182.63M净利润
127.69M总股本
-0.1738每股收益TTM
2.11Beta
-2.98%ROE
8.81052周最低
5.70%振幅
70.39%毛利率
6.14B总市值
8.89回报/风险
4.05%风险率
操作建议
10X Genomics Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名25/200位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价38.46。中期看,股价处于上升通道。近一个月,市场表现很强,基本面评分较高,但很强的走势得没有得到技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
10X Genomics Inc新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Zimmer Biomet Holdings Inc
ZBH
31
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
10X Genomics Inc简介
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
公司代码TXG
公司10X Genomics Inc
CEOSaxonov (Serge Wilson)
网址https://www.10xgenomics.com/
公司股东
常见问题
10X Genomics Inc(TXG)的当前股价是多少?
10X Genomics Inc(TXG)的当前股价是 48.10。
10X Genomics Inc的股票代码是什么?
10X Genomics Inc的股票代码是TXG。
10X Genomics Inc股票的52周最高点是多少?
10X Genomics Inc股票的52周最高点是28.17。
10X Genomics Inc股票的52周最低点是多少?
10X Genomics Inc股票的52周最低点是8.81。
10X Genomics Inc的市值是6.14B。
现在10X Genomics Inc(TXG)的股票是买入、持有还是卖出?
根据分析师评级,10X Genomics Inc(TXG)的总体评级为买入,目标价格为38.46。
10X Genomics Inc(TXG)股票的每股收益(EPS TTM)是多少
10X Genomics Inc(TXG)股票的每股收益(EPS TTM)是-0.35。